PLUSS Awarded European Patent for 'Celsure' Precise Temperature-Controlled Box

New Delhi-based PLUSS Advanced Technology (PLUSS) has been granted patent by European Patent Office, Germany for its ‘Celsure’ box designed and manufactured using the proprietary Phase Change Material (PCM) technology, to transport vaccines and perishable commodities at a specific temperature range.

The material solutions company was granted the patent to the innovative method of arranging PCMs. The method leads to precise temperature control in varying ambient conditions and increases operational efficiencies for the end users. PLUSS has also applied for the patent in US, Singapore, Brazil and India, and expected to be granted soon.

“This is a major endorsement for our research and development and also India’s preparedness in efficient cold chain supply management. These boxes will play a vital role in maintaining precise temperature during transport of various COVID-19 vaccines being tested in India and abroad. The technology is already commercialized and is used by various multinational pharmaceutical and logistics companies in India. We are in conversations with Covid-19 vaccine distribution stakeholders to make our products available across the country. The latest MoU being with Spice Jet,” said Samit Jain, MD, PLUSS.

Transporting pharmaceutical products, biological products or vaccines, especially with India gearing up on vaccine supplychain & logistics, PLUSS’ proprietary, made in India PCM technology will ensure that precise temperature ranges are maintained and at costs much lower than similar international solutions.

PLUSS’ Celsure is a simple-box-in-box transport solution developed by the company’s R&D team using indigenously developed Phase Change Material (PCM) that will maintain the right temperature from a few hours to a few days to ensure that vaccines retain their potency. The company has designed nearly 40 different PCM solutions for different temperatures, ranging from -77 degree Celsius to +89 degree Celsius.

The Tata Capital funded company has made significant strides in PCM technology and has several award-winning solutions and patents for pharma, building and logistics industries in India and overseas. The company started in 1993 with R&D and manufacturing of specialized polymers. In 2006, it started the development in the field of PCMs technology, and received funding from Tata Capital in 2012-13.